TY - JOUR T1 - Association between COVID-19 Risk-Mitigation Behaviors and Specific Mental Disorders in Youth JF - medRxiv DO - 10.1101/2022.03.03.22271787 SP - 2022.03.03.22271787 AU - Kevin P. Conway AU - Kriti Bhardwaj AU - Emmanuella Michel AU - Diana Paksarian AU - Aki Nikolaidis AU - Minji Kang AU - Kathleen R. Merikangas AU - Michael P. Milham Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/03/05/2022.03.03.22271787.abstract N2 - Importance Although studies of adults show that pre-existing mental disorders increase risk for COVID–19 infection and severity, there is limited information about this association among youth. Mental disorders in general as well as specific types of disorders may influence their ability to comply with risk-mitigation strategies to reduce COVID-19 infection and transmission.Objective To examine associations between specific mental disorders and COVID-19 risk-mitigation practices among 314 female and 514 male youth.Design Youth compliance (rated as “Never,” “Sometimes,” “Often,” or “Very often/Always”) with risk mitigation was reported by parents on the CoRonavIruS Health Impact Survey (CRISIS) in January 2021. Responses were summarized using factor analysis of risk mitigation, and their associations with lifetime mental disorders (assessed via structured diagnostic interviews) were identified with linear regression analyses (adjusted for covariates). All analyses used R Project for Statistical Computing for Mac (v.4.0.5).Setting The Healthy Brain Network (HBN) in New York City Participants. 314 female and 514 male youth (ages 5-21)Main Outcome(s) and Measure(s) COVID-19 risk mitigation behaviors among youthResults A two-factor model was the best-fitting solution. Factor 1 (avoidance behaviors) included avoiding groups, indoor settings, and other peoples’ homes; avoidance was more likely among youth with any anxiety disorder (p=.01). Factor 2 (hygiene behaviors) included using hand sanitizer, washing hands, and maintaining social distance; practicing hygiene was less likely among youth with ADHD (combined type) (p=.02). Mask wearing, which did not load on either factor, was not associated with any mental health disorder.Conclusion and Relevance Findings suggest that education and monitoring of risk-mitigation strategies in certain subgroups of youth may reduce risk of exposure to COVID-19 and other contagious diseases. Additionally, they highlight the need for greater attention to vaccine prioritization for individuals with ADHD.Question Are mental disorders among youth associated with COVID-19 risk-mitigation behaviors?Findings Based on the parent CoRonavIruS Health Impact Survey (CRISIS) of 314 females and 514 males aged 5-21, youth with anxiety disorders were more likely to avoid high-risk exposure settings, and those with ADHD (combined type) were less likely to follow hygiene practices. In contrast, mask wearing was not associated with youth mental disorders.Meaning Specific types of disorders in youth may interfere with their ability to employ risk-mitigation strategies that may lead to greater susceptibility to COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Intramural Research Program of the National Institute of Mental Health (ZIAMH002953) and Morgan Stanley. Additionally, by philanthropic gifts from Phyllis Green, Randolph Cowen, and Joe Healey to the Child Mind Institute. The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data are available to researchers by registering for a data usage agreement (http://fcon_1000.projects.nitrc.org/indi/cmi_healthy_brain_network/Pheno_Access.html#DUA).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. ER -